Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Asset Utilization Ratio: 2023-2025

Historic Asset Utilization Ratio for Axsome Therapeutics (AXSM) over the last 3 years, with Sep 2025 value amounting to 0.86.

  • Axsome Therapeutics' Asset Utilization Ratio rose 40.58% to 0.86 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.86, marking a year-over-year increase of 40.58%. This contributed to the annual value of 0.67 for FY2024, which is 13.33% up from last year.
  • As of Q3 2025, Axsome Therapeutics' Asset Utilization Ratio stood at 0.86, which was up 7.09% from 0.80 recorded in Q2 2025.
  • Over the past 5 years, Axsome Therapeutics' Asset Utilization Ratio peaked at 0.86 during Q3 2025, and registered a low of 0.36 during Q2 2023.
  • Its 3-year average for Asset Utilization Ratio is 0.59, with a median of 0.57 in 2024.
  • Data for Axsome Therapeutics' Asset Utilization Ratio shows a peak YoY soared of 67.55% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Axsome Therapeutics' Asset Utilization Ratio stood at 0.46 in 2023, then spiked by 49.99% to 0.68 in 2024, then spiked by 40.58% to 0.86 in 2025.
  • Its Asset Utilization Ratio was 0.86 in Q3 2025, compared to 0.80 in Q2 2025 and 0.74 in Q1 2025.